BioSpace News Archive

A recent government-funded study (Bashash et al. 2017) corroborates hundreds of previously published studies showing fluoride damages the brain.

PathogenDx Corporation announced that company executives Milan Patel, Co-Founder and Chief Executive Officer; Jeff Ryskamp, Chief Financial Officer; Mary Myers, National Sales Director and Magdalena Kedzior, Scientist/Technical Trainer will be available at Booth #1519 at NCIA’s 5th Annual Cannabis Business & Expo in San Jose

Digital Pharmacist Inc. announced that an additional one thousand five hundred pharmacies have adopted its platform in the past 12 months.

While the systemic lupus erythematosus (SLE) pipeline has progressed with agents such as Janssen’s Stelara, AstraZeneca/MedImmune’s anifrolumab, Neovacs’ INF-K, and ImmuPharma’s Lupuzor, historically, most agents in development do not make it past phase III trials, resulting in an exceptionally high unmet need.

Demand for disposable diabetes testing supplies is expected to increase 5.1% annually to more than $3.9 billion in 2022.

Technavio has announced their latest pipeline analysis report on the diabetic neuropathy market. The report includes a detailed analysis of the pipeline molecules under investigation within the defined data collection period to treat diabetic neuropathy.

Technavio has announced their latest pipeline analysis report on gene therapy for sickle-cell diseases. The report includes a detailed analysis of the pipeline molecules under investigation within the defined data collection period for gene therapy for sickle-cell diseases.

BioUtah issued the following statement from President and CEO, Kelly Slone, regarding passage of the Protect Medical Innovation Act of 2017 (H.R. 184) in the U.S. House of Representatives

Patient Insights Accelerate Research And Development

The 14th Annual International Compliance & Ethics Awards will be presented to recipients at the 2018 Compliance & Ethics Institute. Hosted by the Society of Corporate Compliance & Ethics (SCCE), the event will be held October 21-24, 2018 in Las Vegas.